34 units semaglutide hims dosing & Hers announces access to compounded GLP-1 injections for as low as $99/month to U.S. military, veterans, teachers, nurses and first responders Hers/Hims has upped their available – Reglutide SC Injection 1.34 mg/ml

Who Is Found Not For

Some providers are updating their approach from "absolutely avoid" to discussing the risks and benefits on a case-by-case basis

No sales pitch

Cost concerns can be addressed through patient assistance programs offered by pharmaceutical manufacturers

From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies

The goal is building a plan patients can actually stay on